Marija Zivanovic
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Marija Zivanovic has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ana Djuric
Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, Pasterova 14, 11000 Belgrade, Serbia
1 shared publication - Bogdan Aleksandar Šolaja
Serbian Academy of Sciences and Arts, Belgrade, Serbia
1 shared publication - Jelena Grahovac
Institute for Oncology and Radiology of Serbia
1 shared publication - Juan Francisco Santibanez
Group for Molecular Oncology, Institute for Medical Research, National Institute of the Republic of Serbia, University of Belgrade, Belgrade, Serbia
1 shared publication - Ljubodrag Aleksić
Department of Biochemistry & Center of Excellence for Molecular Food Sciences, Faculty of Chemistry, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication - Milan Nikolić
Department of Biochemistry, Faculty of Chemistry, University of Belgrade, 11000 Belgrade, Serbia
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- No. 00,p. 57
4-aminoquinolines promote redox-dependent ferroptosis sensitization in pancreatic ductal adenocarcinoma cells
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer marked by oxidative stress, metabolic rewiring, and resistance to cell death. Ferroptosis, a regulated cell death driven by iron-dependent lipid peroxidation, represents a promising therapeutic vulnerability in PDAC; however, intrinsic resistance to ferroptosis limits its therapeutic exploitation. This study shows that 4-aminoquinoline derivatives sensitize PDAC cell lines (MIA PaCa-2 and PANC-1) to erastin-induced ferroptotic cell death. Ferroptosis sensitization occurred independently of caspase-3/7 activation and was associated with increased ROS production, mitochondrial oxidative stress, lipid peroxidation, and redox imbalance. Importantly, sensitivity to ferroptosis was accompanied by decreased GSH levels, reduced intracellular cystine levels, and differential regulation of the KEAP1-Nrf2-p62 axis. While PANC-1 cells exhibited enhanced oxidative stress and KEAP1 upregulation, MIA PaCa-2 cells maintained relative redox homeostasis unless exposed to combined treatment conditions. To our knowledge, this study provides the first evidence that 4- aminoquinoline derivatives promote sensitization to ferroptosis in PDAC and highlights the therapeutic potential of targeting redox metabolism and stress-adaptive signaling to overcome resistance to therapy in pancreatic cancer.
- 1 January 2026
- Published by National Library of Serbia in Journal of the Serbian Chemical Society
- No. 00,p. 57
Open Access4-aminoquinolines promote redox-dependent ferroptosis sensitization in pancreatic ductal adenocarcinoma cells
Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive cancer marked by oxidative stress, metabolic rewiring, and resistance to cell death. Ferroptosis, a regulated cell death driven by iron-dependent lipid peroxidation, represents a promising therapeutic vulnerability in PDAC; however, intrinsic resistance to ferroptosis limits its therapeutic exploitation. This study shows that 4-aminoquinoline derivatives sensitize PDAC cell lines (MIA PaCa-2 and PANC-1) to erastin-induced ferroptotic cell death. Ferroptosis sensitization occurred independently of caspase-3/7 activation and was associated with increased ROS production, mitochondrial oxidative stress, lipid peroxidation, and redox imbalance. Importantly, sensitivity to ferroptosis was accompanied by decreased GSH levels, reduced intracellular cystine levels, and differential regulation of the KEAP1-Nrf2-p62 axis. While PANC-1 cells exhibited enhanced oxidative stress and KEAP1 upregulation, MIA PaCa-2 cells maintained relative redox homeostasis unless exposed to combined treatment conditions. To our knowledge, this study provides the first evidence that 4- aminoquinoline derivatives promote sensitization to ferroptosis in PDAC and highlights the therapeutic potential of targeting redox metabolism and stress-adaptive signaling to overcome resistance to therapy in pancreatic cancer.